Georgia § 31-52-6 Manufacturers permitted to make investigational drugs, biological products, or devices available

Georgia Statutes

§ 31-52-6 — Manufacturers permitted to make investigational drugs, biological products, or devices available

Georgia § 31-52-6

Title31

This text of Georgia § 31-52-6 (Manufacturers permitted to make investigational drugs, biological products, or devices available) is published on Counsel Stack Legal Research, covering Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

O.C.G.A. § 31-52-6 (2026).

Text

(a)A manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request access to the manufacturer's investigational drug, biological product, or device pursuant to this chapter; provided, however, that nothing in this chapter shall be construed to require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.

(b)A manufacturer may provide an investigational drug, biological product, or device to an eligible patient:

(1)Without receiving compensation; or (2) With the requirement that the eligible patient pays the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.

Free access — add to your briefcase to read the full text and ask questions with AI

(a) A manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request access to the manufacturer's investigational drug, biological product, or device pursuant to this chapter; provided, however, that nothing in this chapter shall be construed to require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient. (b) A manufacturer may provide an investigational drug, biological product, or device to an eligible patient: (1) Without receiving compensation; or (2) With the requirement that the eligible patient pays the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.